Pharmaceutical Science
A topic in the Science corpus, drawn from 673 papers.
Trusted voices in Pharmaceutical Science
Ordered by the trust Pharmaceutical Science's own network concentrates on each researcher, most first.
- R. Müller — trusted by 48 researchers here
- Mark R. Prausnitz — trusted by 33 researchers here
- M. N. R. Kumar — trusted by 39 researchers here
- K. Mäder — trusted by 30 researchers here
- J. Breitenbach — trusted by 25 researchers here
- Colin W. Pouton — trusted by 19 researchers here
- B. Rabinow — trusted by 20 researchers here
- R. Cone — trusted by 12 researchers here
- H. Gill — trusted by 11 researchers here
- J. Siepmann — trusted by 14 researchers here
- Matthew Zeller — trusted by 13 researchers here
- Gerald O. Hunter — trusted by 13 researchers here
Most-cited papers in Pharmaceutical Science
Ordered by the recorded citation count from the source corpus; a citation is not an endorsement.
- Molecular properties that influence the oral bioavailability of drug candidates. (2002, Journal of Medicinal Chemistry) — 7,371 citations
- Engineering precision nanoparticles for drug delivery (2020, Nature reviews. Drug discovery) — 6,130 citations
- A review of chitin and chitosan applications (2000) — 5,755 citations
- Modeling and comparison of dissolution profiles. (2001, European Journal of Pharmaceutical Sciences) — 5,510 citations
- Stimuli-responsive nanocarriers for drug delivery. (2013, Nature Materials) — 5,473 citations
- Fluorine in Pharmaceuticals: Looking Beyond Intuition (2007, Science) — 5,105 citations
- Nano based drug delivery systems: recent developments and future prospects (2018, Journal of Nanobiotechnology) — 5,098 citations
- trans-Dimethanolbis(1,1,1-trifluoro-5,5-dimethylhexane-2,4-dionato)zinc(II) (2008, Acta Crystallographica Section E) — 4,605 citations
- Drug Delivery Systems: Entering the Mainstream (2004, Science) — 4,318 citations
- Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier (2011, Polymers) — 4,247 citations
- Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems (2018, Pharmaceutics) — 4,149 citations
- Designing hydrogels for controlled drug delivery (2016, Nature Reviews Materials) — 4,033 citations
- Fluorine in medicinal chemistry. (2008, Chemical Society Reviews) — 3,994 citations
- PEGylation as a strategy for improving nanoparticle-based drug and gene delivery (2015, Advanced Drug Delivery Reviews) — 3,831 citations
- Fluorine in pharmaceutical industry: fluorine-containing drugs introduced to the market in the last decade (2001-2011). (2014, Chemical Reviews) — 3,665 citations
- Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. (2000, European journal of pharmaceutics and biopharmaceutics) — 3,522 citations
- PLGA-based nanoparticles: an overview of biomedical applications. (2012, Journal of Controlled Release) — 3,515 citations
- HYDROGELS IN DRUG DELIVERY: PROGRESS AND CHALLENGES (2008) — 3,515 citations
- Biodegradable polymeric nanoparticles based drug delivery systems. (2010, Colloids and Surfaces B: Biointerfaces) — 3,504 citations
- Biodegradable nanoparticles for drug and gene delivery to cells and tissue. (2003, Advanced Drug Delivery Reviews) — 3,323 citations
- Biodegradable polymeric nanoparticles as drug delivery devices. (2001, Journal of Controlled Release) — 3,319 citations
- Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. (2010, Angewandte Chemie) — 3,209 citations
- Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). (2001, Advanced Drug Delivery Reviews) — 3,086 citations
- Solid lipid nanoparticles: production, characterization and applications. (2001, Advanced Drug Delivery Reviews) — 3,056 citations
- The many roles for fluorine in medicinal chemistry. (2008, Journal of Medicinal Chemistry) — 2,892 citations
- Chitosan chemistry and pharmaceutical perspectives. (2004, Chemical Reviews) — 2,817 citations
- Improving drug solubility for oral delivery using solid dispersions. (2000, European journal of pharmaceutics and biopharmaceutics) — 2,772 citations
- Liposome: classification, preparation, and applications (2013, Nanoscale Research Letters) — 2,766 citations
- Environment-sensitive hydrogels for drug delivery (2001) — 2,751 citations
- Chitosan—A versatile semi-synthetic polymer in biomedical applications (2011) — 2,689 citations
- Applications of Fluorine in Medicinal Chemistry. (2015, Journal of Medicinal Chemistry) — 2,644 citations
- Nanoparticle-based targeted drug delivery (2009, Experimental and molecular pathology (Print)) — 2,559 citations
- Recent advances on chitosan-based micro- and nanoparticles in drug delivery. (2004, Journal of Controlled Release) — 2,508 citations
- Transdermal drug delivery (2008, Nature Biotechnology) — 2,506 citations
- Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release (2016, Chemical Reviews) — 2,506 citations
- Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. (2010, Biomaterials) — 2,415 citations
- Understanding organofluorine chemistry. An introduction to the C-F bond. (2008, Chemical Society Reviews) — 2,363 citations
- Chitosan-based hydrogels for controlled, localized drug delivery. (2010, Advanced Drug Delivery Reviews) — 2,321 citations
- Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. (2000, New England Journal of Medicine) — 2,255 citations
- The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. (2000, Biomaterials) — 2,166 citations
- Conjugation of chelating agents to proteins and radiolabeling with trivalent metallic isotopes (2006, Nature Protocols) — 2,058 citations
- Effect of Zeta Potential on the Properties of Nano-Drug Delivery Systems - A Review (Part 2) (2013) — 2,038 citations
- Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II-III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas. (2016, Chemical Reviews) — 2,014 citations
- Introduction of fluorine and fluorine-containing functional groups. (2013, Angewandte Chemie) — 1,972 citations
- Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan--a review. (2006, Journal of Controlled Release) — 1,955 citations
- The skin: an indispensable barrier (2008, Experimental Dermatology) — 1,952 citations
- Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer. (2005, Journal of Clinical Oncology) — 1,927 citations
- Cyclodextrin-based pharmaceutics: past, present and future (2004, Nature reviews. Drug discovery) — 1,884 citations
- Dual Catalysis Strategies in Photochemical Synthesis (2016, Chemical Reviews) — 1,869 citations
- Cyclodextrins as pharmaceutical solubilizers. (2007, Advanced Drug Delivery Reviews) — 1,822 citations
Most active researchers
By papers in this topic: a volume measure, not trust.
- R. Müller — 13 papers
- Mark R. Prausnitz — 12 papers
- T. Loftsson — 8 papers
- R. Donnelly — 6 papers
- J. Dressman — 6 papers
- J. Hanes — 5 papers
- Robert Langer — 5 papers
- Nicholas A. Peppas — 5 papers
- J. Siepmann — 5 papers
- Colin W. Pouton — 5 papers
- S. Mitragotri — 5 papers
- Yumin Du — 4 papers